A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Clinical trial NCT06594991 · RECRUITING
Trial details
- NCT number
- NCT06594991
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-10
- Primary completion
- 2027-09-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.